U.S. flag

An official website of the United States government

NM_001366006.2(ADGRL2):c.3065A>C (p.Lys1022Thr) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004308802.1

Allele description [Variation Report for NM_001366006.2(ADGRL2):c.3065A>C (p.Lys1022Thr)]

NM_001366006.2(ADGRL2):c.3065A>C (p.Lys1022Thr)

Gene:
ADGRL2:adhesion G protein-coupled receptor L2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p31.1
Genomic location:
Preferred name:
NM_001366006.2(ADGRL2):c.3065A>C (p.Lys1022Thr)
HGVS:
  • NC_000001.11:g.81979912A>C
  • NM_001297704.3:c.3014A>C
  • NM_001297705.3:c.3014A>C
  • NM_001297706.3:c.3014A>C
  • NM_001330645.3:c.3053A>C
  • NM_001350698.2:c.3065A>C
  • NM_001350699.2:c.3014A>C
  • NM_001366002.2:c.3014A>C
  • NM_001366003.2:c.3065A>C
  • NM_001366004.2:c.3065A>C
  • NM_001366005.2:c.3065A>C
  • NM_001366006.2:c.3065A>CMANE SELECT
  • NM_001366007.2:c.3065A>C
  • NM_001366008.2:c.3065A>C
  • NM_001366009.2:c.3053A>C
  • NM_001393349.1:c.3065A>C
  • NM_001393350.1:c.3053A>C
  • NM_001393351.1:c.3014A>C
  • NM_001393352.1:c.3014A>C
  • NM_001393353.1:c.3014A>C
  • NM_001393354.1:c.3014A>C
  • NM_012302.5:c.3014A>C
  • NP_001284633.1:p.Lys1005Thr
  • NP_001284634.1:p.Lys1005Thr
  • NP_001284635.1:p.Lys1005Thr
  • NP_001317574.1:p.Lys1018Thr
  • NP_001337627.1:p.Lys1022Thr
  • NP_001337628.1:p.Lys1005Thr
  • NP_001352931.1:p.Lys1005Thr
  • NP_001352932.1:p.Lys1022Thr
  • NP_001352933.1:p.Lys1022Thr
  • NP_001352934.1:p.Lys1022Thr
  • NP_001352935.1:p.Lys1022Thr
  • NP_001352936.1:p.Lys1022Thr
  • NP_001352937.1:p.Lys1022Thr
  • NP_001352938.1:p.Lys1018Thr
  • NP_001380278.1:p.Lys1022Thr
  • NP_001380279.1:p.Lys1018Thr
  • NP_001380280.1:p.Lys1005Thr
  • NP_001380281.1:p.Lys1005Thr
  • NP_001380282.1:p.Lys1005Thr
  • NP_001380283.1:p.Lys1005Thr
  • NP_036434.1:p.Lys1005Thr
  • NC_000001.10:g.82445596A>C
  • NM_012302.2:c.3014A>C
  • NR_171658.1:n.3269A>C
Protein change:
K1005T
Molecular consequence:
  • NM_001297704.3:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001297705.3:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001297706.3:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330645.3:c.3053A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350698.2:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350699.2:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366002.2:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366003.2:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366004.2:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366005.2:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366006.2:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366007.2:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366008.2:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001366009.2:c.3053A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393349.1:c.3065A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393350.1:c.3053A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393351.1:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393352.1:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393353.1:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393354.1:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012302.5:c.3014A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_171658.1:n.3269A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Clear Turn Off Turn On
  • soluble scavenger receptor cysteine-rich domain-containing protein SSC5D isoform...
    soluble scavenger receptor cysteine-rich domain-containing protein SSC5D isoform X2 [Rattus norvegicus]
    gi|2678866053|ref|XP_063144760.1|
    Protein
  • Encephalitis, Arbovirus
    Encephalitis, Arbovirus
    Infections of the brain caused by arthropod-borne viruses (i.e., arboviruses) primarily from the families TOGAVIRIDAE; FLAVIVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; and RHABDOVIRIDA...<br/>Year introduced: 2000
    MeSH
  • Educational Technology
    Educational Technology
    Systematic identification, development, organization, or utilization of educational resources and the management of these processes. It is occasionally used also in a more lim...<br/>Year introduced: 1996
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003973052Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Uncertain significance
(Apr 7, 2023) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV003973052.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.3014A>C (p.K1005T) alteration is located in exon 16 (coding exon 15) of the ADGRL2 gene. This alteration results from a A to C substitution at nucleotide position 3014, causing the lysine (K) at amino acid position 1005 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024